Literature DB >> 22115751

Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases.

Wei Zheng1, Andrew D Monnot.   

Abstract

Iron (Fe) and copper (Cu) are essential to neuronal function; excess or deficiency of either is known to underlie the pathoetiology of several commonly known neurodegenerative disorders. This delicate balance of Fe and Cu in the central milieu is maintained by the brain barrier systems, i.e., the blood-brain barrier (BBB) between the blood and brain interstitial fluid and the blood-cerebrospinal fluid barrier (BCB) between the blood and cerebrospinal fluid (CSF). This review provides a concise description on the structural and functional characteristics of the brain barrier systems. Current understanding of Fe and Cu transport across the brain barriers is thoroughly examined, with major focuses on whether the BBB and BCB coordinate the direction of Fe and Cu fluxes between the blood and brain/CSF. In particular, the mechanism by which pertinent metal transporters in the barriers, such as the transferrin receptor (TfR), divalent metal transporter (DMT1), copper transporter (CTR1), ATP7A/B, and ferroportin (FPN), regulate metal movement across the barriers is explored. Finally, the detrimental consequences of dysfunctional metal transport by brain barriers, as a result of endogenous disorders or exogenous insults, are discussed. Understanding the regulation of Fe and Cu homeostasis in the central nervous system aids in the design of new drugs targeted on the regulatory proteins at the brain barriers for the treatment of metal's deficiency or overload-related neurological diseases.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115751      PMCID: PMC3268876          DOI: 10.1016/j.pharmthera.2011.10.006

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  105 in total

1.  Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure.

Authors:  Yueming Jiang; Wei Zheng; Liling Long; Weijia Zhao; Xiangrong Li; Xuean Mo; Jipei Lu; Xue Fu; Wenmei Li; Shouting Liu; Quanyong Long; Jinli Huang; Enrico Pira
Journal:  Neurotoxicology       Date:  2006-08-22       Impact factor: 4.294

2.  A pineal regulatory element (PIRE) mediates transactivation by the pineal/retina-specific transcription factor CRX.

Authors:  X Li; S Chen; Q Wang; D J Zack; S H Snyder; J Borjigin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 3.  Iron nutrition in the UK: getting the balance right.

Authors:  Susan J Fairweather-Tait
Journal:  Proc Nutr Soc       Date:  2004-11       Impact factor: 6.297

Review 4.  The molecular basis of copper and iron interactions.

Authors:  Paul Sharp
Journal:  Proc Nutr Soc       Date:  2004-11       Impact factor: 6.297

5.  Effect of lead exposure and accumulation on copper homeostasis in cultured C6 rat glioma cells.

Authors:  Y Qian; G Mikeska; E D Harris; G R Bratton; E Tiffany-Castiglioni
Journal:  Toxicol Appl Pharmacol       Date:  1999-07-01       Impact factor: 4.219

6.  Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex.

Authors:  S Sastry; G W Arendash
Journal:  Neuroscience       Date:  1995-08       Impact factor: 3.590

7.  Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.

Authors:  W M Pardridge; D Triguero; J Yang; P A Cancilla
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

8.  The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.

Authors:  P L Lee; T Gelbart; C West; C Halloran; E Beutler
Journal:  Blood Cells Mol Dis       Date:  1998-06       Impact factor: 3.039

Review 9.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

10.  Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

Authors:  Carlos Opazo; Xudong Huang; Robert A Cherny; Robert D Moir; Alex E Roher; Anthony R White; Roberto Cappai; Colin L Masters; Rudolph E Tanzi; Nibaldo C Inestrosa; Ashley I Bush
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

View more
  77 in total

1.  Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

Authors:  Steven T Szabo; G Jean Harry; Kathleen M Hayden; David T Szabo; Linda Birnbaum
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

Review 2.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

3.  Baseline blood levels of manganese, lead, cadmium, copper, and zinc in residents of Beijing suburb.

Authors:  Long-Lian Zhang; Ling Lu; Ya-Juan Pan; Chun-Guang Ding; Da-Yong Xu; Chuan-Feng Huang; Xing-Fu Pan; Wei Zheng
Journal:  Environ Res       Date:  2015-03-31       Impact factor: 6.498

4.  Restless legs syndrome/Willis-Ekbom disease prevalence in beta thalassemia patients.

Authors:  Euthimia Dimitriadou; Christoforos D Giannaki; Maria Tsekoura; Ioannis Stefanidis; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Christina Karatzaferi; Giorgos K Sakkas
Journal:  Sleep Breath       Date:  2017-04-19       Impact factor: 2.816

5.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 6.  Copper and the brain noradrenergic system.

Authors:  Svetlana Lutsenko; Clorissa Washington-Hughes; Martina Ralle; Katharina Schmidt
Journal:  J Biol Inorg Chem       Date:  2019-11-05       Impact factor: 3.358

7.  Methanobactin reverses acute liver failure in a rat model of Wilson disease.

Authors:  Josef Lichtmannegger; Christin Leitzinger; Ralf Wimmer; Sabine Schmitt; Sabine Schulz; Yaschar Kabiri; Carola Eberhagen; Tamara Rieder; Dirk Janik; Frauke Neff; Beate K Straub; Peter Schirmacher; Alan A DiSpirito; Nathan Bandow; Bipin S Baral; Andrew Flatley; Elisabeth Kremmer; Gerald Denk; Florian P Reiter; Simon Hohenester; Friedericke Eckardt-Schupp; Norbert A Dencher; Jerzy Adamski; Vanessa Sauer; Christoph Niemietz; Hartmut H J Schmidt; Uta Merle; Daniel Nils Gotthardt; Guido Kroemer; Karl Heinz Weiss; Hans Zischka
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

8.  Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome.

Authors:  Jeanelle Ariza; Craig Steward; Flora Rueckert; Matt Widdison; Robert Coffman; Atiyeh Afjei; Stephen C Noctor; Randi Hagerman; Paul Hagerman; Verónica Martínez-Cerdeño
Journal:  Brain Res       Date:  2014-12-09       Impact factor: 3.252

9.  Manganese accumulation in bone following chronic exposure in rats: steady-state concentration and half-life in bone.

Authors:  Stefanie L O'Neal; Lan Hong; Sherleen Fu; Wendy Jiang; Alexander Jones; Linda H Nie; Wei Zheng
Journal:  Toxicol Lett       Date:  2014-06-12       Impact factor: 4.372

10.  Low-molecular-mass metal complexes in the mouse brain.

Authors:  Sean P McCormick; Mrinmoy Chakrabarti; Allison L Cockrell; Jinkyu Park; Lora S Lindahl; Paul A Lindahl
Journal:  Metallomics       Date:  2013-03       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.